HRTX

NASDAQStock

Heron Therapeutics, Inc.

$0.90-0.03 (-3.27%)

52-Week Range

$0.93
$2.48

Key Stats

Market Cap

141.8M

P/E Ratio

Dividend Yield

Beta

1.30

Volume

1.7M

Avg Volume

2.5M

Performance

1M

-19.31%

3M

-33.72%

6M

-25.17%

YTD

-26.36%

1Y

-60.00%

3Y

-61.18%

5Y

-94.69%

Price Chart

ETF Exposure

HRTX is held by 45 ETFs

ETFFund NameWeight
JFWDJacob Forward ETF1.78%
QQQSInvesco NASDAQ Future Gen 200 ETF0.40%
LNGRGlobal X Aging Population ETF0.15%
IWCiShares Micro-Cap ETF0.03%
VTWVVanguard Russell 2000 Value ETF0.01%
IWNiShares Russell 2000 Value ETF0.01%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
IWMiShares Russell 2000 ETF0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.00%
SCHASchwab U.S. Small-Cap ETF0.00%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.00%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.00%
URTYProShares - UltraPro Russell20000.00%
UWMProShares - Ultra Russell20000.00%
VHTVanguard Health Care ETF0.00%
VXFVanguard Extended Market ETF0.00%
VTWGVanguard Russell 2000 Growth ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
IWOiShares Russell 2000 Growth ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%

About HRTX ETF Exposure

Heron Therapeutics, Inc. (HRTX) is held by 45 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 141.8M, HRTX is a widely held institutional stock. The stock currently trades at $0.90. Investors can gain exposure to HRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HRTX, sorted by portfolio weight.